Alcon Sues Apotex Over Glaucoma Eye Drop ANDA

Law360, New York (October 26, 2009, 2:39 PM EDT) -- Eye care giant Alcon Research Ltd. is seeking to end generic-drug maker Apotex Inc.’s bid to manufacture a generic version of Alcon’s Travatan eye drops, saying Apotex’s abbreviated new drug application infringes five Alcon patents.

Alcon filed its lawsuit Friday in the U.S. District Court for the District of Delaware and asked the court to issue an injunction preventing Apotex from making a generic version of the eye drops, which treat glaucoma and ocular hypertension, because its patents had not yet expired.

Alcon’s Travatan eye drops...
To view the full article, register now.